SOLIUS

SOLIUS® Medical Light Therapy is a biotechnology startup founded in 2011 and headquartered in the United States. The company focuses on developing medical light therapy solutions that harness the beneficial wavelengths of sunlight for healthy living. Their innovative technology emulates the sun's action spectrum to produce Vitamin D and other compounds that stimulate the natural healing powers of the human body, all while mitigating sun exposure risks.

The most recent development for SOLIUS occurred with its Series B investment on 13 May 2020, with Human Longevity as the primary investor. This investment not only underscores market interest but also validates the company's potential to revolutionize medical light therapy. By harnessing the power of light, SOLIUS addresses a critical need in the healthcare industry, positioning itself at the forefront of innovation in wellness technology.

SOLIUS's groundbreaking approach to light therapy presents immense potential for transforming healthcare and wellness. The recent investment serves as a testament to the confidence of industry experts in SOLIUS's vision and technology, propelling it toward further growth and impact in the biotechnology and healthcare sectors.